Article thumbnail

Impaired OXPHOS Complex III in Breast Cancer

By Kjerstin M. Owens, Mariola Kulawiec, Mohamad Mokhtar Desouki, Ayyasamy Vanniarajan and Keshav K. Singh

Abstract

We measured the mitochondrial oxidative phosphorylation (mtOXPHOS) activities of all five complexes and determined the activity and gene expression in detail of the Complex III subunits in human breast cancer cell lines and primary tumors. Our analysis revealed dramatic differences in activity of complex III between normal and aggressive metastatic breast cancer cell lines. Determination of Complex III subunit gene expression identified over expression and co-regulation of UQCRFS1 (encoding RISP protein) and UQCRH (encoding Hinge protein) in 6 out of 9 human breast tumors. Analyses of UQCRFS1/RISP expression in additional matched normal and breast tumors demonstrated an over expression in 14 out of 40 (35%) breast tumors. UQCRFS1/RISP knockdown in breast tumor cell line led to decreased mitochondrial membrane potential as well as a decrease in matrigel invasion. Furthermore, reduced matrigel invasion was mediated by reduced ROS levels coinciding with decreased expression of NADPH oxidase 2, 3, 4 and 5 involved in ROS production. These studies provide direct evidence for contribution of impaired mtOXPHOS Complex III to breast tumorigenesis

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3162009
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A gene expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
  2. (1994). An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria.
  3. (2009). Cancer cell mitochondria confer apoptosis resistance and promote metastasis.
  4. (1961). Coupling of phosphorylation to electron and hydrogen transfer by a chemiosmotic type of mechanism.
  5. (2005). Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors.
  6. (2002). Double minute chromosomes in acute myeloid leukemia and myelodysplasticsyndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping.
  7. (2006). Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors.
  8. (1998). Functional F1-ATPase essential in maintaining growth and membrane potential of human mitochondrial DNA-depleted rho degrees cells.
  9. (2007). Fundamental differences in cell cycle deregulation in human papillomaviruspositive and human papillomavirus-negative head/neck and cervical cancers.
  10. (2002). Fundamentals of Biochemistry.
  11. (2004). Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
  12. (2005). Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia.
  13. (2003). Gene expression profiling identifies molecular subtypes of gliomas.
  14. (1991). Hematoporphyrin-promoted photoinactivation of mitochondrial ubiquinol-cytochrome c reduclase: Selective destruction of the histidine ligands of the iron-sulfur cluster and protective effect of ubiquinone.
  15. (2009). Highresolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.
  16. (2007). Inhibitory effects of nitric oxide on invasion of human cancer cells.
  17. (2005). Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues.
  18. (2009). Mitochondrial dysfunction contributes to oncogene-induced senescence.
  19. (2010). Modifications of protein environment of the [2Fe-2S] cluster of the bc1 complex: effects on the biophysical properties of the rieske iron-sulfur protein and on the kinetics of the complex.
  20. (2004). Molecular classification of parathyroid neoplasia by gene expression profiling.
  21. (2003). Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.
  22. (2009). Mutations in mitochondrial DNA polymerase-g promote breast tumorigenesis.
  23. (2010). NADPH oxidase 4 is an oncogenic protein localized to mitochondria.
  24. (2004). NOX enzymes and the biology of reactive oxygen.
  25. (1956). On the origin of cancer cells.
  26. (2005). Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation.
  27. (1960). Partial resolution of the enzymes catalyzing oxidative phosphorylation. I. Purification and properties of soluble dinitrophenol-stimulated adenosine triphosphatase.
  28. (2006). Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer.
  29. (2006). Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria.
  30. (2006). Redox signalling involving NADPH oxidase-derived reactive oxygen species.
  31. (2008). ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis.
  32. (2005). The iron-sulfur cluster of the rieske ironsulfur protein functions as a proton-exiting gate in the cytochrome bc1 complex.
  33. (2007). The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology.
  34. (2003). Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.
  35. (2008). Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion.
  36. (2004). Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples.